Fred E Cohen - Net Worth and Insider Trading
Fred E Cohen Net Worth
The estimated net worth of Fred E Cohen is at least $6 Million dollars as of 2024-11-13. Fred E Cohen is the Director of Genomic Health Inc and owns about 73,532 shares of Genomic Health Inc (GHDX) stock worth over $5 Million. Fred E Cohen is the Director of BioCryst Pharmaceuticals Inc and owns about 119,410 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $933,786. Fred E Cohen is also the Director of Veracyte Inc and owns about 0 shares of Veracyte Inc (VCYT) stock worth over $0. Details can be seen in Fred E Cohen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fred E Cohen has not made any transactions after 2020-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fred E Cohen
Fred E Cohen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fred E Cohen owns 10 companies in total, including Veracyte Inc (VCYT) , CareDx Inc (CDNA) , and Intellia Therapeutics Inc (NTLA) among others .
Click here to see the complete history of Fred E Cohen’s form 4 insider trades.
Insider Ownership Summary of Fred E Cohen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VCYT | Veracyte Inc | 2020-05-18 | director |
| CDNA | CareDx Inc | 2015-07-01 | director |
| NTLA | Intellia Therapeutics Inc | 2019-01-23 | director |
 | | 2019-01-01 | director |
| | 2021-10-24 | director |
| | 2013-11-13 | director |
| | 2017-09-18 | director |
| | 2017-06-28 | director |
| | 2017-05-10 | director |
| | 2013-05-08 | director |
Fred E Cohen Latest Holdings Summary
Fred E Cohen currently owns a total of 3 stocks. Among these stocks, Fred E Cohen owns 73,532 shares of Genomic Health Inc (GHDX) as of November 8, 2018, with a value of $5 Million and a weighting of 83.32%. Fred E Cohen owns 119,410 shares of BioCryst Pharmaceuticals Inc (BCRX) as of September 18, 2017, with a value of $933,786 and a weighting of 16.68%. Fred E Cohen also owns 0 shares of Veracyte Inc (VCYT) as of May 18, 2020, with a value of $0 and a weighting of 0%.
Latest Holdings of Fred E Cohen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GHDX | Genomic Health Inc | 2018-11-08 | 73,532 | 63.44 | 4,664,870 |
| BCRX | BioCryst Pharmaceuticals Inc | 2017-09-18 | 119,410 | 7.82 | 933,786 |
| VCYT | Veracyte Inc | 2020-05-18 | 0 | 38.25 | 0 |
Holding Weightings of Fred E Cohen
Fred E Cohen Form 4 Trading Tracker
According to the SEC Form 4 filings, Fred E Cohen has made a total of 0 transactions in Genomic Health Inc (GHDX) over the past 5 years. The most-recent trade in Genomic Health Inc is the sale of 10,000 shares on November 8, 2018, which brought Fred E Cohen around $879,300.
According to the SEC Form 4 filings, Fred E Cohen has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 54,250 shares on September 18, 2017, which brought Fred E Cohen around $294,035.
According to the SEC Form 4 filings, Fred E Cohen has made a total of 1 transactions in Veracyte Inc (VCYT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Veracyte Inc is the sale of 40,000 shares on May 18, 2020, which brought Fred E Cohen around $1 Million.
Insider Trading History of Fred E Cohen
- 1
Fred E Cohen Trading Performance
Fred E Cohen Ownership Network
Ownership Network List of Fred E Cohen
Ownership Network Relation of Fred E Cohen
Fred E Cohen Owned Company Details
What does Veracyte Inc do?
Who are the key executives at Veracyte Inc?
Fred E Cohen is the director of Veracyte Inc. Other key executives at Veracyte Inc include Chief Commercial Officer-CLIA John Leite , Chief Scientific & Med Officer Phillip G. Febbo , and director & President & CEO Bonnie H Anderson .
Veracyte Inc (VCYT) Insider Trades Summary
Over the past 18 months, Fred E Cohen made no insider transaction in Veracyte Inc (VCYT). Other recent insider transactions involving Veracyte Inc (VCYT) include a net sale of 131,749 shares made by Evan/ Fa Jones , a net sale of 12,841 shares made by Muna Bhanji , and a net sale of 13,870 shares made by Karin Eastham .
In summary, during the past 3 months, insiders sold 10,652 shares of Veracyte Inc (VCYT) in total and bought 0 shares, with a net sale of 10,652 shares. During the past 18 months, 195,216 shares of Veracyte Inc (VCYT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 195,216 shares.
Veracyte Inc (VCYT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Veracyte Inc Insider Transactions
Fred E Cohen Mailing Address
Above is the net worth, insider trading, and ownership report for Fred E Cohen. You might contact Fred E Cohen via mailing address: 301 Commerce Street, Suite 3300, Fort Worth Tx 76102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
